Baseline medication use is associated with COVID-19 severity in people with rheumatic diseases ...Middle East

- News
Baseline medication use is associated with COVID-19 severity in people with rheumatic diseases
Results from the COVID-19 Global Rheumatology Alliance and the French RMD cohort -- COVID-19 is the disease caused by SARS-CoV-2 infection. It has been suggested that biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) may dampen the inflammatory response in COVID-19, perhaps leading to a less severe clinical course of the infection. However, the way some antirheumatic drugs work might impair the body's natural immune defence against viruses. Two abstracts presented at EULAR 2021 show people taking rituximab or a class of drugs called janus kinase inhibitors (JAKi) have worse COVID-19 severity compared to people taking tumour necrosis factor inhibitors (TNFi). T

Hence then, the article about baseline medication use is associated with covid 19 severity in people with rheumatic diseases was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Baseline medication use is associated with COVID-19 severity in people with rheumatic diseases )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News